Effective treatment of prostate cancer (PCa) remains a major challenge due to chemoresistance to drugs including tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). Ethanol and ethanol ...
Antibodies used were mouse monoclonal anti-TRAIL 2E5 and anti-TRAIL-R1, -R2, -R3 and -R4 (HS101, HS 201, HS 301 and HS401, Alexis, Grünberg, Germany), anti-cytokeratin-18 (cleaved form, clone M30, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results